Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [2461]

A starting point for the development of new pain and cancer drugs

A starting point for the development of new pain and cancer drugs

FDA approves epcoritamab-bysp for follicular lymphoma indications

FDA approves epcoritamab-bysp for follicular lymphoma indications

FDA approves selumetinib for adults with neurofibromatosis type 1 with symptomatic, inoperable plexiform neurofibromas

FDA approves selumetinib for adults with neurofibromatosis type 1 with symptomatic, inoperable plexiform...

New protocol for Treg expansion uses targeted immunotherapy to reduce transplant complications

New protocol for Treg expansion uses targeted immunotherapy to reduce transplant complications

Potential treatment to bypass resistance in deadly childhood cancer

Potential treatment to bypass resistance in deadly childhood cancer

New research reveals the inflammatory mechanism behind VEGF(R) inhibitors, providing new insights into safer cancer treatment

New research reveals the inflammatory mechanism behind VEGF(R) inhibitors, providing new insights into safer...

Pancreatic cancer research project attacks ‘seeds of metastasis’

Pancreatic cancer research project attacks ‘seeds of metastasis’

Medical, recreational cannabis dispensaries lead to reduced opioid prescriptions

Medical, recreational cannabis dispensaries lead to reduced opioid prescriptions

Supervised exercise improves strength and physical performance in patients with advanced breast cancer

Supervised exercise improves strength and physical performance in patients with advanced breast cancer

Common heartburn and blood pressure medicines linked to adverse breast cancer outcomes in large global study

Common heartburn and blood pressure medicines linked to adverse breast cancer outcomes in large global study

More from ecancer